We’re buying more of 2 stocks, deploying some of our cash pile in an oversold market
[ad_1] We’re putting a little more of our big cash position to work Monday into the oversold market. [ad_2] Source link
GE HealthCare Technologies Inc
Read More
Here’s a rapid-fire update on all 36 stocks in the Club’s portfolio, including 2 recent buys
[ad_1] During the Investing Club’s August Monthly Meeting, Jim Cramer provided his latest thinking on all 36 names in his Charitable Trust. [ad_2] Source link
GE HealthCare can surge more than 25% as it capitalizes on key Alzheimer’s opportunity, Wells Fargo says
[ad_1] Wells Fargo is confident GE HealthCare can benefit from the growth of a key Alzheimer’s drug. The firm initiated coverage of the medical device provider with an overweight rating and a $90 per share price target. Wells’ forecast implies nearly 28% upside from Tuesday’s $70.54 close. Analyst Larry Biegelsen highlighted the growth of Alzheimer’s…
Jim Cramer talks about his ‘favorite stock,’ telling investors to buy some as we did last week
[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. U.S. stocks rose Monday, though they’re still having a rough August. Nvidia (NVDA), which has been slumping recently, jumped about 5.5% to start the week. Morgan Stanley reiterated…
Here are the 5 price-target changes and 4 trades we made during this busy earnings week
[ad_1] In a jam-packed week of earnings, the Club executed multiple trades and elevated price targets for some of our biggest stocks. Many of these moves stemmed from what we saw in quarterly numbers and heard on conference calls. Here’s a day-by-day look at the portfolio action. Monday The week began with our decision to…
These health-care companies see opportunity ahead from Alzheimer’s drug approval
[ad_1] As patients with Alzheimer’s disease seek out a newly approved treatment, they will need MRIs, blood tests and other diagnostics, fueling increased demand for these important tools. In earnings calls this week, both GE Healthcare and Quest Diagnostics made references to the potential opportunity here, although neither company put any specific estimates behind their…
Why Cramer thinks this retailer is the ‘ultimate trade-down play’
[ad_1] Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Tuesday’s key moments. Health care in focus ‘Ultimate trade-down play’ Watch the Bullpen 1. Health care in focus Club holdings Danaher (DHR) and GE Healthcare (GEHC) reported better-than-expected earnings before the bell…
Moderna strikes deal to develop mRNA drugs in China
[ad_1] Nikos Pekiaridis | Nurphoto | Getty Images Moderna on Wednesday said it struck a deal with Chinese officials to research, develop and manufacture messenger RNA medicines in the country, despite rising tensions between the U.S. and China. The Massachusetts-based biotech company signed a memorandum of understanding and a related land collaboration deal to develop…
Cramer says snap up this leading medtech stock — wishes he could buy shares too
[ad_1] GE Healthcare (GEHC) shares are sliding Thursday, giving Club members an opportunity to invest in the medical-technology company at an increasingly attractive valuation. The sellers Thursday are making a mistake, and we would capitalize on their misjudgment if not for restrictions that prevent us from trading the stock. Shares of GE Healthcare fell around…
We’re starting a new position in one of the Big 3 global medical imaging and diagnostics companies
[ad_1] This company operates in an $84 billion total addressable market that the company sees growing to around $100 billion by 2024. [ad_2] Source link